Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel backs Teva’s new abuse-deterrent opioid
FDA panel backs Teva’s new abuse-deterrent opioid
FDA panel backs Teva’s new abuse-deterrent opioid
Submitted by
admin
on June 8, 2016 - 9:56am
Source:
Pharma Times
News Tags:
FDA
advisory panels
Teva Pharmaceutical
opioids
Vantrela
abuse-resistant painkillers
Headline:
FDA panel backs Teva’s new abuse-deterrent opioid
Do Not Allow Advertisers to Use My Personal information
